News
The “Top 10” list of best-selling gene therapies published by Genetic Engineering & Biotechnology News (GEN) in their May 2025 issue features three products based upon license agreements for technologies originating from the NIH Intramural Research Program. Featured and ranked on the GEN list are
The Royalties Coordinator administers post-execution license agreements for royalty monitoring and compliance, with more complex assignments performed under the direction of the Supervisory Royalties Analyst. The incumbent serves as a liaison to NIH ICs and the Centers for Disease Control (CDC) by
NIH’s Steven Ferguson will be speaking at the Licensing Executives Society (LES) upcoming virtual seminar titled Industry, Universities, and Government – How to Work Together Through Contracts. This seminar will take place on June 25, 2024 from 10am-1pm EST. “The interface between institutions doing
NIH will be hosting an informational webinar about its recent request for information (RFI) and draft proposal to incorporate patient access planning in the commercialization process for NIH-owned inventions. The webinar will take place on Tuesday, June 11, 3:00 pm – 4:00 pm ET. Presenters will